<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="https://joseph.larmarange.net/spip.php?id_mot=36&amp;page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange</title>
		<url>https://joseph.larmarange.net/local/cache-vignettes/L144xH52/joseph_larmarange_site-6e82f.svg?1649686173</url>
		<link>https://joseph.larmarange.net/</link>
		<height>52</height>
		<width>144</width>
	</image>



<item xml:lang="en">
		<title>Taking test and treat interventions to the next level: Beginning to think what additional information needs to guide public health and operational decisions?</title>
		<link>https://joseph.larmarange.net/taking-test-and-treat</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/taking-test-and-treat</guid>
		<dc:date>2013-06-24T13:57:01Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Activit&#233;s &#233;conomiques</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Milieu rural</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Droits humains</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
John Imrie, Joseph Larmarange, Joanna Orne-Gliemann, Collins Iwuji, France Lert for the ANRS 12249 TasP Study Group. &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
The proposition universal repeat HIV testing and early initiation of antiretroviral treatment for all HIV-positives (UTT) can lead to reduced HIV incidence is being, or will be, tested in several studies. UTT interventions are major social, as well as biomedical interventions, for individuals and target communities. Implementing UTT trial (ANRS 12249&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Activites-economiques-+" rel="tag"&gt;Activit&#233;s &#233;conomiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Milieu-rural-+" rel="tag"&gt;Milieu rural&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Droits-humains-+" rel="tag"&gt;Droits humains&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;

		</description>


 <content:encoded>&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;John Imrie, Joseph Larmarange, Joanna Orne-Gliemann, Collins Iwuji, France Lert for the ANRS 12249 TasP Study Group.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Background&lt;/h2&gt;
&lt;p&gt;The proposition universal repeat HIV testing and early initiation of antiretroviral treatment for all HIV-positives (UTT) can lead to reduced HIV incidence is being, or will be, tested in several studies. UTT interventions are major social, as well as biomedical interventions, for individuals and target communities. Implementing UTT trial (ANRS 12249 TasP Trial) provoked thinking about what is needed for public health and operational decisions to move to the next level if UTT efficacy is demonstrated.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Methods&lt;/h2&gt;
&lt;p&gt;In ANRS 12249 Tasp Trial innovative social science tools are implemented at each UTT stage to ensure a comprehensive understanding of the social determinants of intervention uptake at the individual and community-level and the impacts at individual, household and community level. But these alone cannot guide such a decision.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Results&lt;/h2&gt;
&lt;p&gt;Additional questions requiring answers:&lt;/p&gt;
&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Social and Behavioural consequences of UTT: What are the long-term social and behavioural consequences of large numbers of people knowing their HIV-status and starting treatment early? Will impacts on sexual behaviour, disclosure and stigma necessarily be positive, now and in the long term?&lt;/li&gt;&lt;li&gt; Changes in individual and community norms: Will community perceptions of HIV and healthcare be changed seeing healthy people going to clinics? How are community norms around testing and treatment, stigma and discrimination affected by prolonged, intense research? Can salient positive changes be identified and replicated?&lt;/li&gt;&lt;li&gt; Operational and ethical implications of moving UTT into routine care: Who should lead? What are the sustainability requirements? What ethical issues are there in authorities &#8216;knowing' individuals' HIV status and care uptake?&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Conclusions &lt;/h2&gt;
&lt;p&gt;UTT strategies have potentially great social consequences for the individuals and populations involved. Questions emerging from UTT trials need further enquiry before public health and operational decisions to move beyond the trials are made.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;3FIPFC95&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Imrie&lt;/span&gt; John, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Orne-Gliemann&lt;/span&gt; Joanna, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Lert&lt;/span&gt; France and &lt;span style=&#034;font-variant: small-caps;&#034;&gt;ANRS 12249 TasP Study Group&lt;/span&gt; (2013) &#8220;Taking test and treat interventions to the next level &#8211; Beginning to think what additional information needs to guide public health and operational decisions?&#8221; (poster n&#176;2289118), presented at the &lt;span style=&#034;font-style: italic;&#034; &gt;6th South African AIDS Conference&lt;/span&gt;, Durban.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/tasp_poster_imrie_emerging_issues_sa_aids_2013.pdf" length="1002842" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>Enqu&#234;te Population, Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime 2003</title>
		<link>https://joseph.larmarange.net/Enquete-Population-Pauvrete</link>
		<guid isPermaLink="true">https://joseph.larmarange.net/Enquete-Population-Pauvrete</guid>
		<dc:date>2003-11-03T00:36:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Connaissance du VIH/SIDA</dc:subject>
		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>Guin&#233;e</dc:subject>
		<dc:subject>Mortalit&#233;</dc:subject>
		<dc:subject>Population, Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime</dc:subject>
		<dc:subject>Pauvret&#233;</dc:subject>
		<dc:subject>Mortalit&#233; infanto-juv&#233;nile</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Monographies de village</dc:subject>
		<dc:subject>Ressources &#233;conomiques</dc:subject>
		<dc:subject>Activit&#233;s &#233;conomiques</dc:subject>
		<dc:subject>F&#233;condit&#233;</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Scolarisation</dc:subject>
		<dc:subject>Nuptialit&#233;</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Milieu rural</dc:subject>

		<description>
&lt;p&gt;Cette pr&#233;sentation s'inscrit dans les s&#233;minaires communs aux laboratoires PopInter (Paris 5) et CERPOS (Paris X) qui consitituent l'&#233;quipe d'accueil EA 2324. &lt;br class='autobr' /&gt;
Ce s&#233;minaire a &#233;galement &#233;t&#233; pr&#233;sent&#233; &#224; Conakry (Guin&#233;e), &#224; l'universit&#233; Paris 5, dans le cadre du DEA de sciences sociales de Paris 5 et &#224; l'Universit&#233; de Bourgogne, pendant l'ann&#233;e 2003/2004. &lt;br class='autobr' /&gt; Pr&#233;sentation des r&#233;sultats pr&#233;liminaires de l'enqu&#234;te Population Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime effectu&#233;e en janvier 2003.&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://joseph.larmarange.net/+-Connaissance-du-VIH-SIDA-+" rel="tag"&gt;Connaissance du VIH/SIDA&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Guinee-+" rel="tag"&gt;Guin&#233;e&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mortalite-+" rel="tag"&gt;Mortalit&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Population-Pauvrete-Environnement-+" rel="tag"&gt;Population, Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Pauvrete-+" rel="tag"&gt;Pauvret&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Mortalite-infanto-juvenile-+" rel="tag"&gt;Mortalit&#233; infanto-juv&#233;nile&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Monographies-de-village-+" rel="tag"&gt;Monographies de village&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Ressources-economiques-+" rel="tag"&gt;Ressources &#233;conomiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Activites-economiques-+" rel="tag"&gt;Activit&#233;s &#233;conomiques&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Fecondite-+" rel="tag"&gt;F&#233;condit&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Scolarisation-+" rel="tag"&gt;Scolarisation&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Nuptialite-+" rel="tag"&gt;Nuptialit&#233;&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://joseph.larmarange.net/+-Milieu-rural-+" rel="tag"&gt;Milieu rural&lt;/a&gt;

		</description>


 <content:encoded>&lt;div class='rss_chapo'&gt;&lt;p&gt;Cette pr&#233;sentation s'inscrit dans les s&#233;minaires communs aux laboratoires PopInter (Paris 5) et CERPOS (Paris X) qui consitituent l'&#233;quipe d'accueil EA 2324.&lt;/p&gt;
&lt;p&gt;Ce s&#233;minaire a &#233;galement &#233;t&#233; pr&#233;sent&#233; &#224; Conakry (Guin&#233;e), &#224; l'universit&#233; Paris 5, dans le cadre du DEA de sciences sociales de Paris 5 et &#224; l'Universit&#233; de Bourgogne, pendant l'ann&#233;e 2003/2004.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;p&gt;Pr&#233;sentation des r&#233;sultats pr&#233;liminaires de l'enqu&#234;te &lt;i&gt;Population Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime&lt;/i&gt; effectu&#233;e en janvier 2003. Le texte accompagnant les diapositives est pr&#233;sent dans le fichier Power Point (imprimer pour cela les pages de commentaires).&lt;/p&gt;
&lt;p&gt;Mes &lt;a href='https://joseph.larmarange.net/Mortalite-infantile-Financement-de' class=&#034;spip_in&#034;&gt;m&#233;moires de DEA&lt;/a&gt; portent sur cette enqu&#234;te.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://joseph.larmarange.net/IMG/pdf/semi_ppe_2003.pdf" length="705637" type="application/pdf" />
		
		<enclosure url="https://joseph.larmarange.net/IMG/zip/ppoint_ppe2003.zip" length="4875144" type="application/zip" />
		

	</item>



</channel>

</rss>
